Elevated levels of endocannabinoids, such as 2-arachidonoylglycerol or anandamide, have been implicated in hyperglycemia and decreased insulin sensitivity in high fat fed mice and obese human subjects[111]. The gene discussed is INS; the disease is Hyperglycemia.